S
SecureBio develops technologies and policy proposals to delay, detect, and defend against catastrophic biological threats, whether natural or engineered. The company focuses on restricting dangerous pathogen genome proliferation, enhancing pathogen-agnostic biosurveillance, and developing physical interventions like far-UVC technology. Their efforts aim to reduce global vulnerability to pandemics through proactive security measures across multiple domains.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- SecureBio develops technologies and policy proposals to delay, detect, and defend against catastrophic biological threats, whether natural or engineered. The company focuses on restricting dangerous pathogen genome proliferation, enhancing pathogen-agnostic biosurveillance, and developing physical interventions like far-UVC technology. Their efforts aim to reduce global vulnerability to pandemics through proactive security measures across multiple domains.